🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The 1100 study is an open-label, Phase I, dose escalation and expansion pro...
Status
Active Not Recruiting
Location
University of California San Francisco
Start Date
2019-01-16
Trial ID
NCT03589339
Treatments Being Tested
This is a single institution, single arm phase I/II study of NBTXR3 with ra...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-03-27
Trial ID
NCT07224152
Treatments Being Tested
This phase II trial investigates the effect of NBTXR3, radiation therapy, a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-04-07
Trial ID
NCT04862455
To find the recommended dose of NBTXR3 that can be given in combination wit...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-07-01
Trial ID
NCT04484909
Treatments Being Tested
RATIONALE: Radiation therapy given before surgery of soft tissue sarcoma de...
Status
Completed
Location
Institut Bergonie
Start Date
2011-10
Trial ID
NCT01433068
Treatments Being Tested
This global, open-label, single arm, phase 1b study aims to learn more abou...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-01-26
Trial ID
NCT07219212
Treatments Being Tested
RATIONALE: Radiation therapy given before surgery of soft tissue sarcoma de...
Status
Completed
Location
Capital Region Cancer Service, Canberra Hospital
Start Date
2015-03-03
Trial ID
NCT02379845
Treatments Being Tested
This phase I/II trial studies the side effects and possible benefits of NBT...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-05-08
Trial ID
NCT05039632
Treatments Being Tested
This phase Ib/II study is a prospective, open-label, single arm, nonrandomi...
Status
Terminated
Location
Kaohsiung Medical University Hospital
Start Date
2015-06
Trial ID
NCT02465593
Treatments Being Tested
This phase I trial investigates the best dose and side effects of NBTXR3 wh...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-02-10
Trial ID
NCT04505267
Treatments Being Tested